Physicists and biologists have developed nanoparticles capable of acting as wireless "solar panels" to restore vision in cases of retinal damage. These microscopic particles, administered via injection, replace lost photoreceptors and activate visual signals in the brain.

Development of Light-Sensitive Nanoparticles

An international team of researchers, including experts from Aarhus University (Denmark), has created light-sensitive nanoparticles that can function as microscopic light sensors. Introducing these elements directly into the eye enables the activation of nerve cells in the damaged retina. The results of the study have been published in the journal Nature Biomedical Engineering.

Mechanism of Action

In severe degenerative diseases such as retinitis pigmentosa, the retina’s natural photoreceptors gradually deteriorate, leading to blindness. However, deeper layers of nerve cells, particularly ganglion neurons that transmit visual signals to the brain, remain viable for a long time. The new technology establishes a direct connection with these neurons without the need for surgical implantation of complex electronics or genetic modification.

Structure and Properties of the Nanoparticles

The developed nanoparticles, about 300 nanometers in diameter, are made from a semiconductor material—graphite-like carbon nitride. Structurally, they resemble plant chloroplasts and efficiently absorb visible light.

After injection, the particles distribute evenly across the retinal surface near the neurons. When exposed to light, the nanoparticles trigger local physico-chemical reactions, generating impulses that stimulate neighboring nerve cells to send signals to the brain.

Experimental Results

In experiments with completely blind mice, researchers recorded a response in the visual cortex of the brain when exposed to light, and the animals themselves began to react to changes in illumination through their behavior. The effectiveness of the system was also confirmed in isolated pig retinal tissues.

Advantages of the Technology

The main advantage of this new technology is its versatility. Unlike existing gene therapies, which require individual customization for specific pathologies, or traditional electronic chips that need invasive surgery for implantation, these microscopic "solar panels" are administered through a simple injection and work regardless of the cause of vision loss.

In the coming years, researchers plan to thoroughly study the long-term safety of the material in eye tissues before starting clinical trials in humans.